In silico analysis confirmed the SLC6A14 overexpression in these tumors when compared to both matched normal tissue and pooled GTEx control group, as well as in other epithelial cancers, suggesting a positive correlation between its expression levels and cancer development. Here, SLC6A14 is linked to cancer.